Clinical Trial Update: Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and immunogenicity of GSK's DTPa/Hib vaccine compared with separate DTPa and Hib administration; the study is completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• GSK DTPa/Hib Vaccine (Diphtheria, Tetanus, Acellular Pertussis plus Haemophilus influenzae type b vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tetanus, Diphtheria | Phase 3 | Status: COMPLETED | Results posted: 2017-02-10